pharmagather

Pharmagather

Bullvalene Antibiotics, Of All Things
In the Pipeline
Thursday, April 6, 2023 - 8:00am
Making Alkanes Perform
In the Pipeline
Wednesday, April 5, 2023 - 8:00am
Paxlovid: Drug Development At a Full Sprint
In the Pipeline
Tuesday, April 4, 2023 - 8:00am
Four Trends That Will Pop the $250 Billion Gross-to-Net Bubble—and Transform PBMs, Market Access, and Benefit Design
Drug Channels
Tuesday, April 4, 2023 - 6:30am
A Completely New Microscope Idea
In the Pipeline
Monday, April 3, 2023 - 8:00am
Ask The Oracle (ChatGPT and Chemistry)
In the Pipeline
Friday, March 31, 2023 - 8:00am
Brand-Name Drug Prices Fell for the Fifth Consecutive Year—And Plummeted After Adjusting for Inflation (rerun)
Drug Channels
Friday, March 31, 2023 - 6:30am
The Warped Incentives Behind Amgen’s Humira Biosimilar Pricing–And What We Can Learn from Semglee and Repatha (rerun)
Drug Channels
Thursday, March 30, 2023 - 6:30am
Are Anti-Amyloid Antibodes Going to Make Alzheimer's Patients Worse?
In the Pipeline
Wednesday, March 29, 2023 - 8:00am
CVS, Walgreens, and Walmart Keep Position in 2023 Part D Preferred Networks—While Kroger Bails Over its Express Scripts Blowup (rerun)
Drug Channels
Wednesday, March 29, 2023 - 6:30am
RNA to Protein
In the Pipeline
Tuesday, March 28, 2023 - 8:00am
The Big Three PBMs’ 2023 Formulary Exclusions: Observations on Insulin, Humira, and Biosimilars (rerun)
Drug Channels
Tuesday, March 28, 2023 - 6:30am
Take Your Meds
In the Pipeline
Monday, March 27, 2023 - 8:00am
Behind the GoodRx-Express Scripts Partnership: How PBMs Profit from Discount Cards in Pharmacy Benefits (rerun)
Drug Channels
Monday, March 27, 2023 - 6:30am
Winning the Race for Patient Access: Identifying Copay Accumulator Impact
Drug Channels
Friday, March 24, 2023 - 6:00am
Gene Drives Are Coming
In the Pipeline
Thursday, March 23, 2023 - 8:00am
Organizing Our Thoughts About Cells - Finally
In the Pipeline
Tuesday, March 21, 2023 - 8:00am
Drug Channels News Roundup, March 2023: My $0.02 on Insulin Price Cuts, AbbVie vs. AFPs, Optum Expands, ASAP340B, and Hooray for Pharmacists
Drug Channels
Tuesday, March 21, 2023 - 6:30am
Thumbs Up, Thumbs Down – Minimizing Votes in AdComms
eye on fda
Tuesday, March 21, 2023 - 2:55am
The Right Assay With the Right Cells
In the Pipeline
Monday, March 20, 2023 - 8:00am

Pages

Do Not Allow Advertisers to Use My Personal information

Latest social media